ZA985709B - Encapsulated solution dosage forms of sertraline. - Google Patents

Encapsulated solution dosage forms of sertraline.

Info

Publication number
ZA985709B
ZA985709B ZA9805709A ZA985709A ZA985709B ZA 985709 B ZA985709 B ZA 985709B ZA 9805709 A ZA9805709 A ZA 9805709A ZA 985709 A ZA985709 A ZA 985709A ZA 985709 B ZA985709 B ZA 985709B
Authority
ZA
South Africa
Prior art keywords
sertraline
dosage forms
solution dosage
encapsulated solution
encapsulated
Prior art date
Application number
ZA9805709A
Other languages
English (en)
Inventor
William John Curatolo
Ravi Mysore Shanker
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA985709(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA985709B publication Critical patent/ZA985709B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA9805709A 1997-07-01 1998-06-30 Encapsulated solution dosage forms of sertraline. ZA985709B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5140197P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
ZA985709B true ZA985709B (en) 2000-01-10

Family

ID=21971076

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9805709A ZA985709B (en) 1997-07-01 1998-06-30 Encapsulated solution dosage forms of sertraline.

Country Status (40)

Country Link
EP (1) EP0980241B1 (uk)
JP (1) JP3585245B2 (uk)
KR (1) KR100371730B1 (uk)
CN (1) CN1261792A (uk)
AP (1) AP945A (uk)
AR (1) AR015916A1 (uk)
AT (1) ATE256457T1 (uk)
AU (1) AU724635B2 (uk)
BG (1) BG103917A (uk)
BR (1) BR9809712A (uk)
CA (1) CA2290973C (uk)
CO (1) CO4940405A1 (uk)
DE (1) DE69820608T2 (uk)
DK (1) DK0980241T3 (uk)
DZ (1) DZ2544A1 (uk)
EA (1) EA001905B1 (uk)
ES (1) ES2210760T3 (uk)
GT (1) GT199800090A (uk)
HR (1) HRP980378B1 (uk)
HU (1) HUP0002250A3 (uk)
ID (1) ID24673A (uk)
IL (1) IL133075A0 (uk)
IS (1) IS5266A (uk)
MA (1) MA24586A1 (uk)
MY (1) MY119728A (uk)
NO (1) NO996492L (uk)
NZ (1) NZ501252A (uk)
OA (1) OA11246A (uk)
PA (1) PA8454001A1 (uk)
PE (1) PE97299A1 (uk)
PL (1) PL337807A1 (uk)
PT (1) PT980241E (uk)
SK (1) SK282914B6 (uk)
TN (1) TNSN98123A1 (uk)
TR (1) TR199903282T2 (uk)
TW (1) TW382597B (uk)
UA (1) UA68350C2 (uk)
UY (1) UY25070A1 (uk)
WO (1) WO1999001113A1 (uk)
ZA (1) ZA985709B (uk)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2346335C (en) * 1998-10-13 2006-04-18 Pfizer Products Inc. Sertraline oral concentrate
US6727283B2 (en) 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
AU762934B2 (en) 1999-09-03 2003-07-10 Allergan Sales, Llc Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
WO2002017918A2 (en) 2000-08-30 2002-03-07 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
EP1375659A1 (en) * 2002-06-18 2004-01-02 Laboratorio di Diagnostica Moleculare Soluble capsules containing stock mixtures for easy preparation of chemical or biological solutions
AR041745A1 (es) * 2002-10-31 2005-05-26 Alza Corp Formulacion y forma de dosificacion que provee mayor biodisponibilidad de los farmacos hidrofobos
WO2016020936A2 (en) * 2014-07-21 2016-02-11 Patel Jayendrakumar Dasharathlal A novel oral gastroretentive pharmaceutical dosage form
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0782445B1 (en) * 1994-09-19 2002-03-13 Dupont Pharmaceuticals Company Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence
ATE235237T1 (de) * 1995-07-17 2003-04-15 Pfizer Sertralin zur behandlung von post-myocard-infarkt-patienten

Also Published As

Publication number Publication date
KR100371730B1 (ko) 2003-02-07
CA2290973C (en) 2003-06-17
EA199900963A1 (ru) 2000-08-28
ES2210760T3 (es) 2004-07-01
IL133075A0 (en) 2001-03-19
TW382597B (en) 2000-02-21
DK0980241T3 (da) 2004-04-05
ATE256457T1 (de) 2004-01-15
HUP0002250A3 (en) 2001-01-29
AP9801279A0 (en) 1998-06-30
TR199903282T2 (xx) 2000-08-21
EP0980241A1 (en) 2000-02-23
NO996492D0 (no) 1999-12-27
PL337807A1 (en) 2000-09-11
HRP980378A2 (en) 1999-04-30
AR015916A1 (es) 2001-05-30
MA24586A1 (fr) 1998-12-31
AU7545098A (en) 1999-01-25
EP0980241B1 (en) 2003-12-17
PA8454001A1 (es) 2000-05-24
JP3585245B2 (ja) 2004-11-04
OA11246A (en) 2002-11-19
KR20010013588A (ko) 2001-02-26
SK282914B6 (sk) 2003-01-09
AP945A (en) 2001-02-28
HRP980378B1 (en) 2001-12-31
CN1261792A (zh) 2000-08-02
BG103917A (bg) 2000-07-31
DE69820608D1 (de) 2004-01-29
SK180599A3 (en) 2001-01-18
ID24673A (id) 2000-07-27
PE97299A1 (es) 1999-10-13
DE69820608T2 (de) 2004-12-23
DZ2544A1 (fr) 2003-02-08
MY119728A (en) 2005-07-29
NO996492L (no) 2000-02-29
WO1999001113A1 (en) 1999-01-14
GT199800090A (es) 1999-12-21
UA68350C2 (en) 2004-08-16
BR9809712A (pt) 2000-07-11
TNSN98123A1 (fr) 2005-03-15
JP2000512316A (ja) 2000-09-19
UY25070A1 (es) 2000-12-29
IS5266A (is) 1999-11-23
PT980241E (pt) 2004-03-31
EA001905B1 (ru) 2001-10-22
NZ501252A (en) 2004-11-26
CO4940405A1 (es) 2000-07-24
AU724635B2 (en) 2000-09-28
HUP0002250A2 (hu) 2000-12-28
CA2290973A1 (en) 1999-01-14

Similar Documents

Publication Publication Date Title
PH30784A (en) Encapsulated dosage forms.
ZA99454B (en) Novel dosage form.
HK1030753A1 (en) Fracture healing using pthrp analogs.
ZA982253B (en) Therapeutic compositions.
ZA987551B (en) Solid pharmaceutical dosage forms
ZA981029B (en) Pharmaceutical agents.
ZA9811504B (en) Novel pharmaceutical.
ZA985710B (en) Delayed-release dosage forms of sertraline.
ZA9811506B (en) Novel pharmaceutical.
ZA9811505B (en) Novel pharmaceutical.
ZA985709B (en) Encapsulated solution dosage forms of sertraline.
PL338781A1 (en) Dosage form
SI0980241T1 (en) Gelatine encapsulated solution dosage forms of sertraline
ZA982558B (en) Novel Pharmaceutical.
ZA985707B (en) Sertraline salts and sustained-release dosage forms of sertraline.
HK1014847A1 (en) Body-hair processor.
GB9718683D0 (en) Novel dosage form
GB9704978D0 (en) Dosage forms
GB9719261D0 (en) Dosage forms
EG23239A (en) Preparation of haemagel.
CA82556S (en) Capsule
GB2329335B (en) Medicament
IL120398A0 (en) Low dosage contraceptive
HUP9903097A3 (en) Medicament containing progestogen-anti-progestogen
GB9717408D0 (en) Active trioxanes